Journal of Clinical Oncology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

Journal of Clinical Oncology
Jun 9, 2024, 06:07 | Blog
Thomas J. Ettrich: Final results of our NIFE trial now published in 'Journal of Clinical Oncology'
Thomas J. Ettrich, Senior Physician, Department of Internal Medicine, University of Ulm, shared a post on…
Jun 8, 2024, 07:23 | Opinion
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Jun 4, 2024, 02:42 | Insight
Stanley Ozogbo: Excited to share another abstract publication in the Journal of Clinical Oncology
Stanley Ozogbo, Resident Physician at Mercy Health, shared on X: "Excited to share another abstract publication…
May 30, 2024, 11:10 | Blog
Fumiko Ladd Chino: It's the 2nd annual Yellow Dress Challenge for ASCO24
Fumiko Ladd Chino shared on X/Twitter: "I'm calling an ASCO Fashion audible for those still packing…
May 29, 2024, 15:32 | Insight
Myeloma Paper of the Day, May 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Report of a modified Staging…
May 24, 2024, 14:53 | Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 22, 2024, 15:11 | Insight
Kimryn Rathmell: My editorial with Dr. Catherine Fahey highlighting a recent study by Dr. Joseph Unger
Kimryn Rathmell shared on X/Twitter: "A recent study by Dr. Joseph Unger, Fred Hutchinson Cancer Center +…
May 21, 2024, 12:01 | Blog
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
Jarushka Naidoo shared on X/Twitter: "Phase III trial methylphenidate versus placebo for cancer fatigue in advanced…
May 17, 2024, 15:25 | Blog
Andrea Necchi: Profoundly honored to serve as new Associate Editor ⁦Journal of Clinical Oncology
Andrea Necchi,  Associate Professor of Oncology at Vita-Salute San Raffaele University, shared a post on…
May 17, 2024, 12:54 | Insight
Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer
Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…
May 16, 2024, 14:15 | Insight
Elie G. Dib: Excited to share the results of the TAPUR study
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
May 14, 2024, 10:35 | Insight
RELATIVITY-060 - summarized by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Adding relatlimab to…
May 13, 2024, 13:48 | Blog
Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia…
May 12, 2024, 07:40 | Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 12, 2024, 07:10 | Insight
Cathy Eng: Critical information from Journal of Clinical Oncology
Cathy Eng shared a post by Syed Ahmad, Director University of Cincinnati Cancer Center, on LinkedIn…
May 12, 2024, 04:15 | Blog
Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at The…
May 9, 2024, 12:42 | Blog
Estela Rodriguez: So much work to do to address barriers and develop pragmatic trials
Estela Rodriguez shared on X: “Only 7.1% of patients with cancer participate in clinical trials- so…
May 4, 2024, 10:53 | Dialogues
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In this episode, we…
May 3, 2024, 16:39 | Insight
Thor Halfdanarson: Cannabis in patients with cancer
Thor Halfdanarson, Medical Oncologist focusing on gastrointestinal malignancies at Mayo Clinic, shared on X/Twitter: "Cannabis…
May 1, 2024, 07:00 | Insight
Piotr Wysocki: Cannabis and cannabinoid in adult cancer patients
Piotr Wysocki recently shared on LinkedIn: "ASCO guidelines devoted to cannabis and cannabinoid use in adult…
Apr 26, 2024, 20:26 | Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Apr 25, 2024, 21:06 | Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
Apr 24, 2024, 09:13 | Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 19, 2024, 15:52 | Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 16, 2024, 11:25 | Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 14:38 | Insight
New Paper Alert! Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response
Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response Authors: Carmine Valenza,…
Apr 14, 2024, 03:52 | Drugs
Piotr Wysocki: CLEAR trial – another study demonstrating that Immunotherapy and TKI combination should not be routinely recommended to favorable-risk RCC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 12, 2024, 11:15 | Insight
Robert Miller: How many adult patients with cancer participate in clinical trials?
Robert Miller, Chief Medical Science Officer at CancerLinQ, shared on LinkedIn: "How many adult patients…
Apr 8, 2024, 22:37 | Insight
Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…
Apr 8, 2024, 08:41 | Insight
Elizabeth Budde: We reported the longest follow-up of using BsAbs in lymphoma
Elizabeth Budde, Associate Professor at City of Hope, shared on X/Twitter: "We reported the longest…
Apr 8, 2024, 03:26 | Insight
Lisa A. Lacasse: Researchers released new findings this week in the Journal of Clinical Oncology
Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ASC CAN), shared…
Apr 7, 2024, 16:02 | Blog
Emre Yekedüz: What a great news from ASCO!
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, made the following post on X:…
Apr 2, 2024, 18:56 | Drugs
Shushan Hovsepyan: What is the optimal way of effective drug development for ultra-rare cancers?
Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, shared a…
Mar 31, 2024, 23:12 | Insight
Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 30, 2024, 11:36 | Insight
Piotr J. Wysocki: Pembrolizumab remains the only drug active in adjuvant settings in RCC – updated results of the ECOG-ACRIN E2810 on adjuvant pazopanib
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 29, 2024, 18:54 | Insight
Shushan Hovsepyan: Exploring new drugs for ultra-rare cancers?
Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, posted on…
Mar 28, 2024, 02:31 | Insight
Rami Manochakian: New Supportive Care Guideline by ASCO on Vaccination of adult with cancer
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: "Hot off…
Mar 24, 2024, 12:56 | Career
Smita Bhatia Receives the 2024 ASCO-American Cancer Society Cancer Prevention Award
The American Society of Clinical Oncology (ASCO) has announced Smita Bhatia, MD, MPH, FASCO as the recipient…
Mar 22, 2024, 15:23 | Blog
Piotr J. Wysocki: Regular, personalized follow-up in breast cancer survivors may not improve long-term outcomes but significantly improves patients’ quality of life
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a…
Mar 18, 2024, 19:36 | Insight
Alisa Kamalyan: Our article "Cancer and Armed Conflict: Crossing Realities" remains relevant as various armed conflicts continue to unfold
Alisa Kamalyan, Head of Psychosocial Services at the Yeolyan Hematology and Oncology Center, posted on LinkedIn:…
Mar 18, 2024, 15:28 | Blog
Vivek Subbiah: Universal germline, in addition to tumor somatic, genomic testing is needed to win the war against cancer
Vivek Subbiah recently shared a post on X/Twitter: “Pleased to share Universal Germline and Tumor…
Mar 16, 2024, 20:07 | Insight
Erman Akkus: HER2 and mCRC on Journal of Clinical Oncology
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "HER2 and mCRC on…
Mar 16, 2024, 15:39 | Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 15, 2024, 18:27 | Blog
Mehdi Hamadani: Much awaited Blood and Marrow Transplant Clinical Trials Network 1506 trial out in the Journal of Clinical Oncology
Mehdi Hamadani, Director of the Bone Marrow Transplantation and Cellular Therapy Program at the Medical…
Mar 15, 2024, 18:07 | Insight
Talazoparib in Combination With Enzalutamide for Prostate Cancer - FDA Oncology
FDA Oncology posted on X/Twitter: "FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment…
Mar 14, 2024, 09:38 | Blog
Caryn Lerman: Dr. Heinz Josef Lenz and his team investigated the potential prognostic and predictive value of HER2 amplification and gene expression using NGS and NanoString data
Mar 5, 2024, 01:35 | Insight
Timothée Olivier: Final results of ASCENT in patients with TNBC…
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by Markus…
Mar 4, 2024, 17:27 | Drugs
Piotr Wysocki: Anthracyclines must always be considered in the adjuvant treatment of breast cancer patients- final results of ABC trials
Piotr Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University Hospital…
Mar 3, 2024, 01:59 | Insight
Erman Akkus: Does primary tumor resection prolong OS in inoperable synchronous metastatic CRC?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Does primary tumor resection…
Mar 2, 2024, 23:40 | Blog
Rami Manochakian: ASCO Living Guideline Update by great experts Journal of Clinical Oncology
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Feb 29, 2024, 19:29 | Blog
Nuh Rahbari: The SYNCHRONOUS and CCReIV trials on primary tumor resection in metastatic colon cancer
Nuh Rahbari, Chairman and Professor of Surgery, Department of General and Visceral Surgery at University…
Feb 21, 2024, 17:10 | Insight
Patients with breast cancer residing in areas with low opportunity have high allostatic load and worse mortality - Journal of Clinical Oncology
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Feb 16, 2024, 18:13 | Blog
Elisa Agostinetto: Nice editorial out in Journal of Clinical Oncology on the design, analysis, and reporting of research that involves real-world data
Elisa Agostinetto, Research Fellow at Jules Bordet Institute, shared a post on X/Twitter: "Nice editorial out…
Jan 30, 2024, 10:56 | Blog
Stephen V Liu: Congratulations to Drs. Glenn J. Hanna, Annie Silk and team - huge achievement!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 29, 2024, 10:40 | Blog
Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting
Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter: "Excited for…
Jan 26, 2024, 17:17 | Societies
30 Posts Not To Miss From ASCO GI24
The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…
Jan 23, 2024, 18:44 | Insight
Todd Aguilera: We must educate and rethink
Todd Aguilera, Radiation Oncologist at UT Southwestern Medical Center, recently tweeted: "We must educate and…
Jan 19, 2024, 14:06 | Insight
Mark Awad: Our group's effort to elucidate mechanisms of resistance to PD-1 immunotherapy in lung cancer
Mark Awad, Director of Clinical Research, Associate Professor of Thoracic Oncology at the Dana-Farber Cancer…
Jan 18, 2024, 15:55 | Blog
Biagio Ricciuti: Mechanisms of acquired resistance to PD-(L)1 blockade in NSCLC
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn: “Now out in the…
Jan 14, 2024, 17:31 | Insight
Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma
Nizar Jacques Bahlis, Associate Professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine,…
Jan 13, 2024, 15:13 | Blog
Lucas Moreno: The first publication from the BEACON-Neuroblastoma trial is now live in the Journal of Clinical Oncology
Lucas Moreno, Division Head of Paediatric Oncology and Haematology at Vall d'Hebron Barcelona Hospital Campus, shared…
Jan 13, 2024, 14:58 | Blog
Nicola Gökbuget: GMALL Initial-1 Trial has been published in the Journal of Clinical Oncology
Nicola Gökbuget, Head of Clinical Trial Center at Goethe University Hospital, shared a post on LinkedIn:…
Jan 6, 2024, 12:09 | Insight
Bishal Gyawali: Here is a list of our top 10 publications from 2023
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Happy New…
Dec 31, 2023, 20:07 | Blog
Katsuaki Maehara: Patritumab Deruxtecan (HER3-DXd) clinical trial transition
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared a post by EGFR Resisters on X/Twitter,…
Dec 29, 2023, 05:18 | Blog
U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on their X/Twitter page: ''Breaking from Journal of…
Dec 26, 2023, 13:35 | Insight
Erman Akkus: SUMMARIES OF 5 TOP-READ ARTICLES OF Journal of Clinical Oncology and JCO Precision Oncology in 2023!
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "SUMMARIES OF 5 TOP-READ…
Dec 23, 2023, 16:40 | Blog
Paolo Tarantino: Proud to see our article among the JCO Oncology Practice 5 most-read articles in 2023
Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a post by Journal…
Dec 23, 2023, 15:58 | Blog
Vivek Subbiah: Here's to four decades of impactful research!
Vivek Subbiah shared on X/Twitter: "Milestone alert! Celebrating Journal of Clinical Oncology's 40th anniversary. Huge…
Dec 20, 2023, 11:38 | Blog
Celebrating Journal of Clinical Oncology's 40th
Journal of Clinical Oncology shared a post on X/Twitter: "Celebrating JCO's 40th: Congrats to the…
Dec 17, 2023, 01:51 | Insight
Eleonora Teplinsky: Can we omit radiation for low risk patients after lumpectomy?
Eleonora Teplinsky shared on LinkedIn: “New Trial presented at SABCS 2023 by Dr. Reshma Jagsi…
Dec 16, 2023, 11:19 | Insight
Caryn Lerman: Heinz Josef Lenz and his team identified novel predictive and prognostic biomarkers
Caryn Lerman, Director of USC Norris Comprehensive Cancer Center, shared on LinkedIn: "Published in the…
Dec 13, 2023, 17:58 | Blog
Justin Stebbing: My piece on genes and race in colon cancer has just been published by the Journal of Clinical Oncology
Justin Stebbing shared a post on LinkedIn: "My piece on genes and race in colon cancer…
Nov 29, 2023, 17:32 | Blog
Lynn M. Schuchter: Journal of Clinical Oncology’s Art of Oncology beautifully showcases the human side of medicine
Lynn M. Schuchter shared Journal of Clinical Oncology's post on X/Twitter, adding: "Journal of Clinical…
Oct 27, 2023, 04:45 | Opinion
Mark Lewis: Oncologists should read this and re-evaluate their relationship with their pharmacy colleagues
Mark Lewis shared Kristen McCullough's post on Twitter, adding: "Oncologists should read this and re-evaluate their relationship…
Oct 20, 2023, 20:06 | Insight
Nina Niu Sanford: Our work on clinical trial endpoints and inclusion criteria in GI oncology trials
Nina Niu Sanford, Chief of Gastrointestinal Radiation Oncology Service at UT Southwestern Medical Center, shared…
Oct 17, 2023, 01:30 | Stories
Narjust Florez: Vulnerability is powerful and storytelling is healing
Narjust Florez shared on Twitter: "Vulnerability is powerful and storytelling is healing. Honored to be…
Sep 3, 2023, 17:28 | Insight
Jess Scott: More benefits of exercise - pan-cancer analysis of more than 11,000 patients.
Jess Scott, an exercise oncology researcher at Memorial Sloan Kettering Cancer Center, recently tweeted: "More…
Aug 27, 2023, 18:59 | Insight
Antonio Marra: In an analysis of more than 28k pts, pancreatic acinar cell carcinoma was the cancer type with the highest prevalence of gBRCA2 and HRD features.
Quoting Antonio Marra, medical oncologist at the European Institute of Oncology, on Twitter: "Our latest…
Aug 21, 2023, 16:51 | Insight
Ishwaria Subbiah: New guidelines on non-pharmacologic options for cancer symptom management.
Ishwaria Subbiah, the Executive Director of Cancer Care Equity and Professional Wellness at Sarah Cannon…
May 28, 2023, 16:27 | Opinion
As an oncology community we still have a lot to do, that more and more children do not need to go into the palliative care clinic and get cured - Gevorg Tamamyan
Quoting Gevorg Tamamyan on LinkedIn, "When people ask me, isn't it difficult to work as…
All: 280 Posts: 201 - 300
Special Coverage